Keyphrases
Melanomagenesis
100%
DNA Damage
66%
Melanoma
66%
Melanocytes
42%
Malignant Progression
28%
Effective Dose
28%
DNA Repair
19%
Cancer Development
19%
Genetic Modification
19%
Solar Radiation
19%
Cell Cycle Checkpoint
19%
Defective DNA
14%
Malignant Melanoma
14%
Chromosomal Instability
14%
Medical Intervention
14%
DNA Damage Checkpoint
14%
Human Melanocytes
14%
Types of Melanoma
14%
Neoplastic Transformation
14%
Oncogene mutation
14%
Risk Assessment Methods
14%
Melanoma Progression
14%
Melanocytic Tumor
14%
Inactivating mutation
14%
Metastatic Melanoma
14%
Ink4a
14%
Activating mutation
14%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
14%
Functional Defects
14%
Multistage Development
14%
Single-cell Clone
14%
Genome Destabilization
14%
Prognostic Value
14%
DNA Damage Response
9%
UV-induced
9%
Therapeutic Value
9%
Suppressor Genes
9%
Carcinogen
9%
Melanoma Cells
9%
UV-induced DNA Damage
9%
Computational Model
9%
Nucleotide Excision Repair
9%
Functional Assay
9%
Double-strand Break Repair
9%
In Vivo Model
9%
Environmental Carcinogenesis
9%
Environmental Carcinogens
9%
Lessons Learned
9%
Mutator Phenotype
9%
Post-replication Repair
9%
Checkpoint Response
9%
Specific Types
9%
Public Health Risk
9%
Chromosomal Aberrations
9%
Clonal Expansion
9%
Tumor Suppressor
9%
Potential Therapeutics
9%
Chromosomal Damage
9%
Systems Biology Approach
9%
Biochemistry, Genetics and Molecular Biology
Melanocyte
100%
DNA Damage Response
66%
Gene Mutation
33%
Cell Cycle Checkpoint
33%
DNA Repair
33%
Solar Radiation
33%
DNA Damage
33%
Chromosome Instability
25%
Suppressor Gene
16%
Mouse
16%
Oncogene
16%
Nucleotide Excision Repair
16%
Chromosomal Aberration
16%
Base Excision Repair
16%
Postreplication Repair
16%
Carcinogenesis
16%
Tumor Suppressor Protein
16%
Developmental Stage
16%
Murine
16%
Medicine and Dentistry
DNA Damage Response
66%
Nodular Melanoma
66%
Melanocyte
36%
Cell Cycle Checkpoint
18%
DNA Damage
12%
Carcinogen
12%
DNA Repair
12%
Gene Mutation
12%
Malignant Neoplasm
12%
Melanoma Cell Line
9%
Suppressor Gene
9%
Developmental Stage
9%
Cutaneous Melanoma
9%
Medical Intervention
9%
Mutagenic Agent
9%
Chromosomal Instability
9%
Postreplication Repair
9%
Tumor Suppressor Protein
6%
Carcinogenesis
6%
Public Health
6%
Chromosome Aberration
6%
Biological Marker
6%
Oncogene
6%
Base Excision Repair
6%